U.S. Markets open in 5 hrs 40 mins

MannKind Corporation (MNKD)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.30-0.06 (-4.41%)
At close: 4:00PM EDT
People also watch
  • Well, I've really burned the midnight oil this time. Devoted my ENTIRE weekend, having no time for summer fun, to troll this message board. I sure hope my bosses are happy!
    GOD, my life sucks........
  • How about some MATH!! I just KNOW how much BAGHOLDERS LOVE MATH! Let's FIRST examine FIRST what the FORTY "un-dedicated" sales reps achieved from THEIR start on about 7/8/16:

    Nrx = 84

    Refills = 132

    Trx = 216

    ...to their their PEAK just THREE MONTHS later on 10/7/2016:

    Nrx = 152

    Refills = 157

    Trx = 305

    Got THAT? Okay! NEXT, let's look at what the OVER ONE HUNDRED "dedicated" sales reps achieved from about when THEY started on about 2/17/17:

    Nrx = 109

    Refills = 138

    Trx = 247

    ...to what they reported Friday -- FIVE plus MONTHS later:

    Nrx = 159

    Refills = 161

    Trx = 320

    So the FORTY UN-dedicated reps produced increases of

    Nrx = 68

    Refills = 25

    Trx = 89

    ...in THREE months while the OVER ONE HUNDRED dedicated reps produced:

    Nrx = 50

    Refills = 23

    Trx = 73

    Oh, MY! Would you look at THAT! The FORTY did MORE in THREE months than the OVER ONE HUNDRED did in FIVE months.

    INDEED, after FIVE months those OVER ONE HUNDRED DEDICATED reps have only just about MATCHED the script numbers that FORTY UNdedicated reps achieved in THREE months.

    And to think those UNdedicated reps didn't have Damon Dash, Jeff Dachis, or Charles Mattocks touting for them EITHER!

    I'll leave it to the BAGHOLDERS to calculate how much MORE those over ONE HUNDRED dedicated reps is costing THEM versus what the FORTY UNdedicated ones cost.


  • HERNIATING loops of BOWEL after reading:


    "Means a ton"

    HAW!!! NO, what it MEANS is the CLOWN realizes his PREMIERE had LESS than 46,000 viewers -- and most of THOSE were BAGHOLDERS -- while his SPONSOR is approaching BANKRUPTCY!


    Charles Mattocks on Twitter
    “I need a Oprah connect.”
  • LOL! Truly pathetic. Charles Mattock desperately trying to reach out to Oprah because his show with absolutely pathetic viewership numbers. Desperation at its finest. Almost more pathetic than MNKD longs


    Imgur: The most awesome images on the Internet
    Imgur: The most awesome images on the Internet.
  • OLD yet INTERESTING history from 2013:



    "'As far as we know, there is no-one out there with a product that infringes our patents. I like to think our patents haven’t been challenged because they’re so strong, but the real explanation is probably that we don’t have a product on the market yet, so there’s not a big motivation for someone else to challenge it. If we’re successful, it’s very conceivable this will happen, and we’ll respond appropriately,' he adds."

    And no doubt BAGHOLDERS have NOTICED that so far NO ONE has challenged ANY of MNKD's patents! HINT, HINT!!

    Then again, who but MNKD would want a patent on DOGSH_T!

    But even FUNNIER is that the guy being quoted, David Diamond, LEFT mannkind in October of 2016:


    NO doubt he realized MNKD would NEVER need HIS services to help protect those PATENTS!


    MNKD: Message Board for MannKind Corporation - InvestorVillage
    MannKind Corporation Message board - Online Community of active, educated investors researching and discussing MannKind Corporation Stocks.
  • Uh-oh! Looks like that 20 TON shipment of afizzle NEVER left the dock for the UAE! NO big deal though since the UAE apparently doesn't even KNOW afizzle EXISTS:


    But NO MATTER, it looks like they at least STILL got EXUBERA!



    Looks like the UAE still has EXUBERA! But GUESS WHAT!
    Imgur: The most awesome images on the Internet.
  • ROFLMAO!!!! Yeah! "Sportsrancho" is one of the bigger NUTBALLS on proboards' "mnkcirclejerk" forum!

    The THING is, SHE has some sort of OCD that FORCES her to post EVERY SINGLE TWEET saying ANYTHING good about MNKD! She has been PARTICULARLY attentive to Charles Mattocks and his afizzle touting "reality show"!

    So I KNEW I could depend on her to post EVERY kind thing ANYONE tweeted about "reversed"! Well, GUESS WHAT! It's been FIVE DAYS now since the "premiere" and what FEW comments have been tweeted have ALL come from BAGHOLDERS:


    Go FIGURE! HAW!!!!

    Afrezza in Blogs and Social Media | MannKind MNKD Message Board
    Posts and links to Afrezza blogs and Social Media
  • Yeah! BAGHOLDERS are no doubt THRILLED with all the INTEREST that the TV commercial and Charles Mattocks' reality show, "reversed," brought to afizzle:


    Look at THAT! Why, it's NECK and NECK with DOGSH_T! Go FIGURE!


    "Reversed" TV show really BOOSTED interest in afrezza!
    Imgur: The most awesome images on the Internet.
  • Looks like the BAGHOLDERS on the proboards' "mnkdcirclejerk" forum are getting more RESTLESS:

    1) "nadathing":

    "Matt said 18 months ago they were looking for a partner with epi if I am not mistaken. Have they even started trials? Did they give us any hard information at the shareholders meeting? My guess is that the project is dead. Call me a pessimist, but I haven't seen a paying TS deal yet, other than a million bucks or so from RLS."

    2) "thall":

    "A question from a previous conference call that I wondered about: www.mannkindcorp.com/Collateral/Documents/English-US/MNKD%202%203%2016%20Investor%20Call%20FAQ%20v2%209%2016%20FINAL.pdf

    "Can the insulin from Pfizer be used and is it cleared by the FDA? It has been stated to be sufficient to manufacture $10B of product."

    Just prior to the agreement with Sanofi, MannKind completed CMC studies and a clinical bioequivalence study leading to a potential submission of the HMR 4006 insulin acquired from Pfizer. Based on the current age of the HMR 4006 inventories, MannKind is evaluating various options and utility for future use. There is currently sufficient inventory of Amphastar insulin for near term needs."

    What happened with that?"

    Yeah! The REALITY sooner or LATER begins to FINALLY sink IN!


  • GASP!!!! MEGABull(sh_tter) and MODERATOR of proboards' "mnkdcirclejerk" forum is GRIPING about Mannkind FAILING to live up to expectatiotns:

    "Michael Castagna was quoted in an interview that he considered the Afrezza pediatric trials to be the highest priority. The target date for enrollment was June 15, but they had to have missed it. The FDA requires companies to file the details of trials to be published at the ClinicalTrial.gov website no later than 21 days after the first enrollment.

    Mike was right. The ped trial is HUGE and I don't understand the delay. I suspect that lack of funding is the issue. Our new CEO had better explain it at the upcoming calls when he presents his strategic plan for Afrezza and MannKind. If he doesn't, then Wall Street may view him as just another paper tiger.

    As a shareholder, I expect him to communicate a viable plan in a few weeks and then to deliver results."

    I'm willing to bet THAT sends CHILLS down the backs of the BAGHOLDERS!!
  • MNKD bagholder's motto:
  • IF you want to HEAR total FAILURE in MOTION, just check out my FAILED music career!!
  • Meanwhile at MNKD headquarters
  • Wanna see FAILURE in MOTION? Try COMPARING today's Nrx of 159 to the Nrx for some diabetic drugs for JUST the EIGHTH week after their original launch:

    Victoza 3,264

    Byetta 3,877

    Januvia 15,212

    YES! Those numbers are for just ONE WEEK and they are for just the EIGHTH WEEK after their initial LAUNCH! Afizzle is now TWO and a HALF YEARS after its initial launch and has add TWO ADDITIONAL launches in the meantime!

    Does anyone REALLY need to look up the definition of the word DOOM?

  • I can hear the BAGHOLDERS whining already:


    The FUNNY thing is that the article doesn't even BOTHER to mention afizzle! Then again, since afizzle is STUCK with THIS statement from the insert:

    "AFREZZA provided less HbA1c reduction than insulin aspart, and the difference was statistically significant. More subjects in the insulin aspart group achieved the HbA1c target of ≤7%."

    ...maybe the author just figured there never WOULD be any decent insurance coverage for it, so why even BOTHER to worry about LOSING it!


    Insurers Heavily Restrict Diabetes Coverage in 2017
  • BAGHOLDERS can BET that Solomon Steiner -- the INVENTOR of technosphere -- knew how PATHETIC TODAY'S NEW SCRIPT NUMBERS:

    Nrx = 159

    Refills = 161

    Trx = 320

    ...would be!

    Yeah! He LEFT Mannkind around 2003, 10 YEARS after selling them the technology, and then started his own company -- "Biodel" -- for delivering -- are you ready for this? -- an "ultra-rapid-acting concentrated insulin" using an INJECTION! REALLY now? Go figure!

    He also later started Perosphere which ALSO does NOT use inhalation to deliver ITS product.

    What does THAT tell you about what HE thinks of inhaled medications?

    I mean, if the INVENTOR not ONLY abandoned ship FOURTEEN YEARS AGO, but went on to form TWO companies, NEITHER of which use technosphere, that OUGHT to tell you what the INVENTOR himself thinks about the potential of TS and afizzle! Right?
  • MORE awesome analysis from Spencer Osborne:


    "In essence, MannKind is juggling this financial overhang at the very same time that it is considering a marketing push. Something has to give, and more likely than not it will come at the expense of the common shareholder. "

    So what ELSE is NEW -- right?


    MannKind: Afrezza Scripts Stable At A Bit Above 300 - Will Ads Help?
    Afrezza scripts come in at 320. Television ads have now run. Cash situation remains top priority.
  • BAGHOLDERS just HATE it when I post articles like THIS:


    "Novo's Victoza wins backing of FDA panel on CV benefit"

    "Sales of Trulicity totaled $373 million in the first QUARTER of 2017, up 160% from the same period a year ago. And Lilly executives believe the Trulicity brand strength among ENDOCRINOLOGISTS compares to Victoza, perhaps signaling further STRENGTH in the future."

    In what CENTURY does ANYONE with an IQ greater than squirrel's testicle believe that afizzle will reach 373 MILLION in a CENTURY!


    Novo's Victoza wins backing of FDA panel on CV benefit
    A vote in favor of Victoza's cardiovascular benefit moves the Danish drugmaker closer to winning an expanded label for the important GLP-1 drug.
  • Mnkd long captured in the background
  • Seems apropos after today's NEW SCRIPT NUMBERS:

    Nrx = 159

    Refills = 161

    Trx = 320